Meng Jiahao, Yan Zeya, Cheng Wei, Wang Zilan, Chen Zhouqing, You Wanchun, Wang Zhong
Department of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, Suzhou, China.
Transl Cancer Res. 2023 Feb 28;12(2):439-446. doi: 10.21037/tcr-22-1942. Epub 2023 Jan 9.
Thyroid cancer has low incidence and mortality. While metastatic cancer is the most common type of intracranial cancer, patients with intracranial metastases from thyroid cancer very rarely present with seizures. Here, we describe a case study and review the neurological symptoms and histopathology of intracranial metastases from thyroid cancer.
A 38-year-old woman was diagnosed with intracranial metastases from papillary thyroid cancer, with the chief symptom being generalized seizures. The bilateral frontal masses were completely resected in 2 operations, after which the patient was treated with whole-brain radiotherapy and tyrosine kinase inhibitors (TKIs). It has now been over 13 years since thyroid cancer resection and 51 months since she was diagnosed with intracranial metastases from papillary thyroid cancer. The long-term survival might be due to the effective and prompt treatment. Through literature review, we found the incidence of intracranial metastases from different subtypes of thyroid cancer to be inconsistent with epidemiological findings in thyroid cancer.
Intracranial metastases of thyroid cancer should be considered when the patient has a history of thyroid cancer with seizures. A combination of surgery, radiation therapy, and TKI drugs may prolong survival.
甲状腺癌的发病率和死亡率较低。虽然转移性癌是颅内癌最常见的类型,但甲状腺癌颅内转移患者很少出现癫痫发作。在此,我们描述一例病例研究,并回顾甲状腺癌颅内转移的神经症状和组织病理学。
一名38岁女性被诊断为甲状腺乳头状癌颅内转移,主要症状为全身性癫痫发作。通过两次手术将双侧额叶肿块完全切除,术后患者接受了全脑放疗和酪氨酸激酶抑制剂(TKIs)治疗。自甲状腺癌切除至今已过去13年多,自她被诊断为甲状腺乳头状癌颅内转移至今已过去51个月。长期生存可能得益于有效且及时的治疗。通过文献回顾,我们发现甲状腺癌不同亚型的颅内转移发生率与甲状腺癌的流行病学研究结果不一致。
当患者有甲状腺癌病史且出现癫痫发作时,应考虑甲状腺癌颅内转移。手术、放疗和TKI药物联合使用可能延长生存期。